SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mishra, A.
Right arrow Articles by Hobbs, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, A.
Right arrow Articles by Hobbs, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Other

Does Quetiapine Have Mood Altering Properties?

Achal Mishra

Mental Health Unit, Leazes Wing, Royal Victoria Infirmary, Newcastle Upon Tyne., achdoc{at}aol.com

P. Brian Moore

Tranwell Unit, Windy Nook Road, Gateshead, UK.

Rosemary Hobbs

Tranwell Unit, Windy Nook Road, Gateshead, UK.

We present a series of three cases who developed manic symptoms on introduction of quetiapine to their medication regime. All were male, with long-standing psychotic illnesses (schizophrenia/schizoaffective disorder), relatively well maintained on medication until their deterioration which prompted a review of their medication. The dose range of prescribed quetiapine was 300-800 mg daily. Two patients had previously received antidepressants without displaying manic symptoms. The mania subsided on withdrawal of quetiapine in two patients. The third patient continued on quetiapine but with the addition of zuclopenthixol depot. Sodium valproate was prescribed to the other two patients, and quetiapine was discontinued. These cases indicate that a side-effect of quetiapine may be mood elevation. An ability to elevate mood while controlling psychoses would be helpful in the treatment of post-psychotic and bipolar depression. Its clinical importance in the control of manic episodes, for which atypical antipsychotics are used increasingly, is uncertain.

Key Words: mania • psychoses • quetiapine • schizoaffective illness • schizophrenia

Journal of Psychopharmacology, Vol. 18, No. 2, 281-284 (2004)
DOI: 10.1177/0269881104042635


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
F.-G. B. Pajonk, A. K. Schwertner, and M. A. Seelig
Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series
J Psychopharmacol, January 1, 2006; 20(1): 119 - 124.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C. H. Ashton, P. B. Moore, P. Gallagher, and A. H. Young
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
J Psychopharmacol, May 1, 2005; 19(3): 293 - 300.
[Abstract] [PDF]



Advertisement